Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Drug Delivery and Translational Research|March 20, 2015
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedropsTina T Wong, Gary D Novack, Jayaganesh V Natarajan, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 17, 2013
Randomized, double-masked, placebo-controlled study to assess the ocular safety of mirabegron in healthy volunteersGary D Novack, Richard A Lewis, Roger Vogel, et al.
Ophthalmology. Glaucoma|September 2, 2022
Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular HypertensionPaul J Hartman, David L Cooke, Henry H Hsu, et al.
Ophthalmology|May 17, 2003
Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucomaMaria F Delgado, Christopher J Dickens, Andrew G Iwach, et al.
American Journal of Ophthalmology|December 5, 2017
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)Janet B Serle, L Jay Katz, Eugene McLaurin, et al.
American Journal of Ophthalmology|January 18, 2019
Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)Malik Y Kahook, Janet B Serle, Francis S Mah, et al.
The Ocular Surface|July 25, 2017
TFOS DEWS II Clinical Trial Design ReportGary D Novack, Penny Asbell, Stefano Barabino, et al.
The Ocular Surface|April 10, 2012
Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet needDavid A Sullivan, Katherine M Hammitt, Debra A Schaumberg, et al.
The Ocular Surface|January 18, 2016
Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye TreatmentWendy Chao, Carlos Belmonte, José M Benitez Del Castillo, et al.
The Ocular Surface|August 12, 2017
TFOS DEWS II Report Executive SummaryJennifer P Craig, J Daniel Nelson, Dimitri T Azar, et al.
Pageof 5